Navigation Links
STEMCELL Technologies Inc. Introduces MethoCult Express for Cord Blood Banks and Transplant Centers
Date:10/8/2009

STEMCELL Technologies Inc. (STEMCELL), a Vancouver-based life sciences company, announces the launch of MethoCult® Express, an innovative methylcellulose-based medium specifically formulated to allow enumeration of total colony-forming cells after only 7 days of culture.

Vancouver, British Columbia (PRWEB) October 8, 2009 -- STEMCELL Technologies Inc., a Vancouver-based life sciences company, announces the launch of MethoCult® Express, an innovative methylcellulose-based medium specifically formulated to allow enumeration of total colony-forming cells after only 7 days of culture. With this new medium, reliable information on hematopoietic progenitor cell numbers in cord blood can be obtained much earlier than with standard 14-day assays.

"Assessment of the stem and progenitor cell content of cord blood units is a critical, time-sensitive step for cord blood banks and transplant centers," says Bert Wognum, Senior Scientist at STEMCELL Technologies. "Performing CFC-assays in MethoCult® Express allows faster, easier and more standardized assessment of progenitor numbers than 14-day assays. Obtaining accurate CFC-assay results in as early as 7 days may be very helpful for cord blood banks and transplant centers because the need to assess the progenitor cell content and quality of cord blood units during processing and cryopreservation may assist in selecting the most suitable graft for transplantation." With MethoCult® Express, cultures can also be maintained for a total of 14 - 16 days to permit identification of different colony types on the basis of morphological criteria similar to standard CFC-assays.

For more information about MethoCult® Express, visit http://www.stemcell.com/news_info/methocult_express.aspx.

About STEMCELL Technologies
STEMCELL Technologies Inc is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research. Driven by science and enabled by close interactions with global leaders in cell biology and medicine, STEMCELL delivers over 900 products to research scientists in more than 70 countries worldwide. To learn more about how STEMCELL helps to make research work, visit www.stemcell.com.

Contact
Kenneth To, PhD, MBA, Product Manager - Hematology
STEMCELL Technologies Inc.
604-675-7807

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3010954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. STEMCELL Technologies Inc. Announces Direct Distribution to Spain
2. STEMCELL Technologies Applauds Feeder-free Derivation of Human Induced Pluripotent Stem Cells
3. STEMCELL Technologies Inc. to Host Stem Cell Training Courses
4. STEMCELL Technologies Launches Direct Distribution to Singapore
5. STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
6. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
7. RAM Technologies Named to Philadelphia Business Journals List of Top Tech Employers
8. Arcxis Biotechnologies Announces Release of First Commercial Product for Molecular Analysis
9. Connectyx Technologies Retained the Marcum Group in New York as its Independent Registered Public Accountant for the Purpose of Becoming a Fully Reporting Company
10. ReBuilder Medical Technologies, Inc. Announces Medicare Billing Ability for its ReBuilder Product
11. TeleTracking Technologies Adds RTLS for Fully Automatic Patient Flow Automation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... consumers can save an average of 70% when buying medication online from Canadian ... are available when purchasing from other countries. The report (chart below) compares U.S. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in ... teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their primitive ... been used to remove decayed dental matter, and that teeth were then filled with ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
(Date:4/18/2017)... , April 18, 2017  Spero Therapeutics, LLC, a ... treatment of bacterial infections, will present preclinical data supporting ... of multidrug resistant (MDR) Gram-negative infections at the 27th ... April 22-25, 2017 in Vienna, Austria ... ...
Breaking Medicine Technology: